Atopic Dermatitis

Chronic, relapsing inflammatory skin disease driven by type 2/Th2 immune dysregulation and epidermal barrier dysfunction, presenting as pruritic, eczematous lesions; the most common chronic inflammatory skin disease in both adults and children.

Phase 1/2 and later readouts in Atopic Dermatitis, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

Total attributable cost

$98.8B

$4,979/patient

Drug spend

$23.2B

$1,168/patient

How this is calculated ↗

All severities, self-reported diagnosis (2024 NHIS) · US

All assets in Atopic Dermatitis

← Dermatology